Stocktoria
CUMBERLAND PHARMACEUTICALS INC CPIX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2009-08-11
CUMBERLAND PHARMACEUTICALS INC statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -6.3% | -17.0% | -24.2% | -13.6% | -21.3% |
| Net margin | -6.4% | -17.1% | -15.9% | -13.3% | -9.7% |
| FCF margin | 10.9% | -1.8% | 14.7% | 19.9% | 17.3% |
| Return on assets | -3.7% | -8.6% | -7.7% | -6.0% | -4.2% |
| Return on equity | -11.4% | -28.4% | -21.2% | -15.4% | -8.2% |
| Current ratio | 1.01 | 1.15 | 1.28 | 1.60 | 2.37 |
| Revenue growth | 17.6% | -4.3% | -5.9% | 16.7% | -3.9% |
Source: SEC EDGAR filings · CIK 0001087294 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.